Using tailored meals to improve health for people with HIV and diabetes
Food as Medicine for HIV: A Randomized Trial of Medically Tailored Meals and Lifestyle Intervention
This study is looking at how special meals made just for people with HIV and type 2 diabetes can help improve their health and make it easier for them to manage their diabetes while also addressing issues with not having enough food.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10994159 on NIH RePORTER |
What this research studies
This research investigates how medically tailored meals can help individuals living with HIV who also have type 2 diabetes. The study aims to address food insecurity, which is common in this population and can worsen health outcomes. Participants will receive meals specifically designed by dietitians to meet their medical needs, along with lifestyle interventions to improve their overall health. The goal is to see if these tailored meals can lead to better management of diabetes and reduce the risk of complications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals over 21 years old living with HIV and type 2 diabetes who experience food insecurity.
Not a fit: Patients who do not have HIV or type 2 diabetes may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve health outcomes for patients with HIV and diabetes by enhancing their diet and lifestyle.
How similar studies have performed: Previous research has shown that medically tailored meal programs can improve health outcomes for individuals with chronic conditions, indicating potential success for this approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Berkowitz, Seth a — Univ of North Carolina Chapel Hill
- Study coordinator: Berkowitz, Seth a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.